schizophrenia

Indivior secures FDA approval for Perseris to treat schizophrenia

Specialty pharmaceutical company Indivior has secured the US Food and Drug Administration (FDA) approval for the use of its Perseris…

Alkermes’ Aristada Initio approved by FDA for schizophrenia

Irish biopharmaceutical company Alkermes has received approval from the US Food and Drug Administration (FDA) for the use of its…